BRÈVE publiée le 28/10/2024 à 13:35, il y a 25 jours 20 heures EnVVeno Medical lance une étude préclinique pour la valve enVVe EnVVeno Medical Approbation De La FDA Traitement CVI Étude BPL Soupape EnVVe
COMMUNIQUÉ DE PRESSE publié le 28/10/2024 à 13:30, il y a 25 jours 20 heures enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R) enVVeno Medical Corporation successfully completes first wave of implants with updated delivery system for enVVe replacement venous valve, on track for U.S. pivotal trial in mid-2025 EnVVeno Medical Corporation Venous Disease Implants EnVVe Pivotal Trial
BRÈVE publiée le 27/09/2024 à 03:23, il y a 1 mois 26 jours EnVVeno Medical Corporation annonce le prix d'une offre publique de 15 millions de dollars EnVVeno Medical Offre Publique Maladie Veineuse Valve VenoValve Groupe Titan Partners
BRÈVE publiée le 27/09/2024 à 03:23, il y a 1 mois 26 jours EnVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering Public Offering EnVVeno Medical VenoValve Venous Disease Titan Partners Group
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 03:18, il y a 1 mois 26 jours enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering enVVeno Medical Corporation announces pricing of underwritten public offering for the treatment of venous disease. Offering led by Titan Partners Group. Expected gross proceeds of $15.0 million Public Offering Gross Proceeds EnVVeno Medical Corporation Venous Disease Titan Partners Group
BRÈVE publiée le 26/09/2024 à 22:10, il y a 1 mois 26 jours EnVVeno Medical Corporation Announces Proposed Public Offering SEC Filing Public Offering EnVVeno Medical VenoValve Venous Disease
BRÈVE publiée le 26/09/2024 à 22:10, il y a 1 mois 26 jours EnVVeno Medical Corporation annonce un projet d'offre publique d'achat EnVVeno Medical Dépôt Auprès De La SEC Maladie Veineuse Valve VenoValve Offre Publique De Vente
COMMUNIQUÉ DE PRESSE publié le 26/09/2024 à 22:05, il y a 1 mois 26 jours enVVeno Medical Corporation Announces Proposed Public Offering enVVeno Medical Corp. proposes public stock offering through underwritten public offering for venous disease treatment products. Funding for R&D and corporate needs Medical Devices EnVVeno Medical Corporation Venous Disease Treatment Public Stock Offering R&D Funding
BRÈVE publiée le 03/09/2024 à 15:05, il y a 2 mois 19 jours EnVVeno Medical nomme Sandy Prietto au poste de vice-président du marketing Dispositifs Médicaux EnVVeno Medical Approbation De La FDA Valve VenoValve Sandy Prietto
BRÈVE publiée le 03/09/2024 à 15:05, il y a 2 mois 19 jours EnVVeno Medical Appoints Sandy Prietto as VP of Marketing Medical Devices FDA Approval EnVVeno Medical VenoValve Sandy Prietto
Publié le 22/11/2024 à 16:15, il y a 18 heures 12 minutes NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Publié le 21/11/2024 à 06:58, il y a 2 jours 3 heures Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 22/11/2024 à 23:55, il y a 10 heures 33 minutes Boron One Announces Early Warrant Exercise Incentive Program
Publié le 22/11/2024 à 23:30, il y a 10 heures 58 minutes Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Publié le 22/11/2024 à 23:05, il y a 11 heures 23 minutes Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Publié le 22/11/2024 à 22:30, il y a 11 heures 58 minutes Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Publié le 22/11/2024 à 18:14, il y a 16 heures 13 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 22/11/2024 à 17:53, il y a 16 heures 34 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 22/11/2024 à 16:55, il y a 17 heures 32 minutes EQS-Adhoc: Comment on withdrawn non-binding offer
Publié le 22/11/2024 à 16:00, il y a 18 heures 28 minutes Proposed cancellation of admission to trading
